LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 35.77 | 21.74 | 2184 | 2602 | 0.8391 | 0.9498 | MN20160310_N01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 35.77 | 21.74 | 1784 | 2602 | 0.6854 | 0.8935 | MN20160310_N01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 35.77 | 21.74 | 2335 | 2602 | 0.8971 | 0.9688 | MN20160310_N01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 37.74 | 21.74 | 122 | 2828 | 0.0431 | 0.2784 | MN20160310_N01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 37.74 | 21.74 | 2406 | 2828 | 0.8507 | 0.9545 | MN20160310_N01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 37.74 | 21.74 | 2050 | 2828 | 0.7248 | 0.9104 | MN20160310_N01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 37.74 | 21.74 | 2546 | 2828 | 0.9002 | 0.9703 | MN20160310_N01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 39.71 | 21.74 | 164 | 3084 | 0.0532 | 0.3267 | MN20160310_N01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 39.71 | 21.74 | 2613 | 3084 | 0.8472 | 0.9542 | MN20160310_N01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 39.71 | 21.74 | 2061 | 3084 | 0.6683 | 0.8904 | MN20160310_N01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 39.71 | 21.74 | 2735 | 3084 | 0.8868 | 0.9667 | MN20160310_N01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 41.68 | 21.74 | 191 | 3418 | 0.0559 | 0.3469 | MN20160310_N01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 41.68 | 21.74 | 2905 | 3418 | 0.8497 | 0.9559 | MN20160310_N01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 41.68 | 21.74 | 2127 | 3418 | 0.6222 | 0.8741 | MN20160310_N01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 41.68 | 21.74 | 2935 | 3418 | 0.8585 | 0.9586 | MN20160310_N01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 43.65 | 21.74 | 208 | 3754 | 0.0554 | 0.3551 | MN20160310_N01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 43.65 | 21.74 | 3136 | 3754 | 0.8353 | 0.9522 | MN20160310_N01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 43.65 | 21.74 | 2123 | 3754 | 0.5655 | 0.8523 | MN20160310_N01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 43.65 | 21.74 | 3187 | 3754 | 0.8489 | 0.9564 | MN20160310_N01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 45.62 | 21.74 | 285 | 4150 | 0.0687 | 0.4044 | MN20160310_N01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 45.62 | 21.74 | 3395 | 4150 | 0.8179 | 0.9476 | MN20160310_N01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 45.62 | 21.74 | 2286 | 4150 | 0.5507 | 0.8486 | MN20160310_N01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 45.62 | 21.74 | 3373 | 4150 | 0.8126 | 0.9460 | MN20160310_N01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 47.59 | 21.74 | 230 | 4492 | 0.0512 | 0.3590 | MN20160310_N01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 47.59 | 21.74 | 3705 | 4492 | 0.8248 | 0.9505 | MN20160310_N01 | D14 |